25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China
Clinical trial NCT02328118 · UNKNOWN
Trial details
- NCT number
- NCT02328118
- Sponsor
- JUNYAN ZHANG
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2017-03-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.